VTGN Earnings

VTGN reported its FY2026Q3 earnings on 2026-02-12, showcasing a revenue of 0.00 against an estimate of 540.00K, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.5 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following VTGN's FY2026Q3 earnings announcement on 2026-02-12, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, VTGN's stock price tends to shift by an average of -3.90% in the 10 days leading up to earnings and +1.31% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate VTGN’s annual revenue to reach 219.00K, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 56.79% and EPS estimates Revise Upward by 22.15% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between VTGN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Upward by 56.79%, while EPS estimates moved Revise Upward by 22.15% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, VTGN's stock price typically moves by -3.90% in the 10 days before its earnings and +1.31% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 0.00 and revenue of 219.00K.

The earnings call presents a mixed sentiment. Financial sustainability is stable with $77.2 million in cash, but competition and regulatory risks pose challenges. The Q&A reveals some uncertainty in trial execution, though commercialization plans are underway. The lack of discussion on shareholder returns and unclear responses regarding patient screen failures add to uncertainty. Without strong positive catalysts like new partnerships or record revenues, and considering the market's competitive nature, the stock price is likely to remain stable in the short term, resulting in a neutral sentiment rating.